These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 2839628

  • 1. Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension.
    Frishman WH, Goldberger J, Sherman D.
    J Clin Hypertens; 1987 Dec; 3(4):520-7. PubMed ID: 2839628
    [Abstract] [Full Text] [Related]

  • 2. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
    Clin Ther; 1993 Dec; 15(2):364-73. PubMed ID: 8519044
    [Abstract] [Full Text] [Related]

  • 3. Treatment of essential hypertension in Asians: enalapril as monotherapy versus combination therapy with hydrochlorothiazide.
    Jones DW, Sands CD.
    Pharmacotherapy; 1991 Dec; 11(2):127-30. PubMed ID: 2052467
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hypertension in the very old.
    Otterstad JE, Ruilope LM.
    Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of the antihypertensive effect of enalapril by randomized addition of different doses of hydrochlorothiazide.
    Dahlöf B, Andrén L, Eggertsen R, Jern S, Svensson A, Hansson L.
    J Hypertens Suppl; 1985 Dec; 3(3):S483-6. PubMed ID: 2856773
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of a combination of enalapril and hydrochlorothiazide in the treatment of hypertension measured manually and with an ambulatory blood pressure monitor.
    Weir MR, Lavin PT, Byrnes CA.
    Clin Ther; 1993 Dec; 15(3):527-38. PubMed ID: 8364944
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
    Velasco M, Morillo J, Urbina A, Kögler P, Leishman B, Pasquier M, Hernändez-Pieretti O.
    Int J Clin Pharmacol Res; 1987 Dec; 7(6):443-54. PubMed ID: 3440635
    [Abstract] [Full Text] [Related]

  • 9. [Comparative study of enalapril, hydrochlorothiazide and their combination in the treatment of essential hypertension].
    Vaisse B, Souchet T, Delage Y, Poggi L.
    Ann Cardiol Angeiol (Paris); 1991 Jan; 40(1):51-4. PubMed ID: 2024911
    [Abstract] [Full Text] [Related]

  • 10. Treatment of hypertension by enalapril and hydrochlorothiazide separately and together: a multicenter study.
    Rosenthal T, Grossman E, Rathaus M, Bernheim J, Zevin D, Levi J, Weinstein J, Rogel S.
    Isr J Med Sci; 1990 Feb; 26(2):63-6. PubMed ID: 2180849
    [Abstract] [Full Text] [Related]

  • 11. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF, Kulaga SF, Kramsch DM.
    J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
    [Abstract] [Full Text] [Related]

  • 12. The efficacy of hydrochlorothiazide, timolol and enalapril in Ethiopians with essential hypertension.
    Habte B.
    Ethiop Med J; 1992 Jul; 30(3):163-7. PubMed ID: 1396619
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of enalapril (20 mg)/hydrochlorothiazide (12.5 mg) combination therapy in essential hypertension.
    Strocchi E, Bossini A, Ranieri G, Filitti V.
    Clin Ther; 1991 Jul; 13(6):737-46. PubMed ID: 1790548
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 15. Long-term antihypertensive, metabolic and cellular effects of enalapril.
    Malini PL, Strocchi E, Ambrosioni E, Magnani B.
    J Hypertens Suppl; 1984 Dec; 2(2):S101-5. PubMed ID: 6100870
    [Abstract] [Full Text] [Related]

  • 16. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
    Naidoo DP, Sareli P, Marin F, Aroca-Martinez G, Maritz FJ, Jardim PC, Guerrero AA, Thompson CA, Bero T, Drazka J, Kosmalova V, Dumortier T, Smith RD.
    Adv Ther; 1999 Dec; 16(5):187-99. PubMed ID: 10915394
    [Abstract] [Full Text] [Related]

  • 17. Hydrochlorothiazide and verapamil in the treatment of hypertension. The Verapamil Versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H, Distler A, Michaelis J, Philipp T, Wellek S.
    J Cardiovasc Pharmacol; 1991 Dec; 18 Suppl 6():S33-7. PubMed ID: 1725915
    [Abstract] [Full Text] [Related]

  • 18. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 20. [Spirapril in the therapy of mild and moderately severe hypertension. A Czech and Slovak multicenter study].
    Widimský J, Lánská V, Hulínský V.
    Vnitr Lek; 1995 Nov; 41(11):744-52. PubMed ID: 8553592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.